<DOC>
	<DOCNO>NCT02312934</DOCNO>
	<brief_summary>The purpose study evaluate use nicotine patch treatment problem attention , learn memory breast cancer patient 1-5 year post chemotherapy .</brief_summary>
	<brief_title>Nicotinic Treatment Post-Chemotherapy Subjective Cognitive Impairment : A Pilot Study</brief_title>
	<detailed_description>Studies suggest chemotherapy treatment breast cancer may change way brain function . As result , patient receive chemotherapy breast cancer may experience problem attention , learning , memory receive chemotherapy . The investigator find nicotine treatment help type patient similar difficulty attention , learning , memory . Nicotine naturally occur substance find tobacco know interact nerve cell brain important function like learn memory , study number disorder . This study design test whether nicotine treatment helpful learn memory problem chemotherapy breast cancer . This study randomize , placebo-controlled pilot study evaluate effect transdermal nicotine 1 ) reduce subjective complaint 2 ) enhance cognitive performance laboratory measure cognitive performance breast cancer patient persistent chemotherapy-related cognitive impairment ( CRCI ) , condition also know `` chemo brain . '' Participants randomize either placebo active compound ( 50/50 ) 6-week treatment portion study . Participants assess , , end treatment . At end 8-week study , participant option take part open-label portion study additional 6 week .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>All participant : 1 . Be 35 80 year age , 2 . Have diagnose noninvasive invasive ( Stage 1 , 2 , 3A ) breast cancer , 3 . Have undergone treatment systemic chemotherapy within last 15 year , 4 . Endorse persistent CRCI subjective complaint , 5 . Be nonsmoker ( nicotine use within last 5 year ) , 6 . Have active cardiac , neurologic , psychiatric illness , 7 . Fluent able read English . Participants exclude : 1 . Any active neurologic and/or psychiatric disease , history significant head trauma follow persistent neurologic deficit , know structural brain abnormality , 2 . Current major depression another major psychiatric disorder describe DSM5 ( use CNS active medication ( e.g . antidepressant ) permit , provide dose stable least 3 month ) , 3 . Any history alcohol substance abuse dependence within past 2 year ( DSM5 criterion ) , 4 . Any significant systemic illness unstable medical condition could lead difficulty comply protocol include : History myocardial infarction past year unstable , severe cardiovascular disease include angina CHF symptom rest , clinically significant abnormality ECG Clinically significant and/or unstable pulmonary , gastrointestinal , hepatic , renal disease Insulinrequiring diabetes uncontrolled diabetes mellitus , Uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) , 5 . Use investigational drug within 30 day 5 halflives , whichever longer , prior screen , 6 . Use drug procholinergic property ( e.g . donepezil ) .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Chemo brain</keyword>
	<keyword>Chemotherapy-related cognitive impairment</keyword>
	<keyword>CRCI</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Chemo fog</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Transdermal nicotine</keyword>
</DOC>